The Jackson Laboratory is a leading provider of cancer mouse models and in vivo oncology services and a National Cancer Institute-designated Cancer Center. Drawing on decades of research experience we provide capabilities around model selection, husbandry and customizable oncology studies to help clients and researchers evaluate novel anti-cancer therapies. Our diverse oncology study protocols range from traditional xenograft services to PDX cancer models and advanced humanized mouse models for immuno-oncology drug development. www.jax.org
Our mission is to provide the premier collection of well-characterized models and services for drug discovery to help our clients reduce the attrition rate of candidate compounds by improving molecule selection, as well as identifying patients who will benefit most from a treatment regimen. Crown Bioscience Inc. is a cutting edge translational technology company with expertise in the disease areas of oncology, inflammation, and cardiovascular and metabolic disease. We are known for the breadth and quality of our in vitro and in vivo models, as well as our ability to help clients quantify the real efficacy and pharmacological profile of their candidate before they move into the clinic. www.crownbio.com
Mitra Biotech is a global leader in advancing personalized cancer treatment and empowering drug development & discovery. Our phenotypic CANscript platform delivers powerful insight for our biopharma partners. Because CANscript conserves the native tumor microenvironment and delivers 1:1 clinical correlation, it can be used to predict response of an indication to a specific drug (or drug combination), or to better understand MOA of a given compound. Founded in 2010, Mitra is headquartered in Boston and maintains a significant research and laboratory presence in Bangalore, India. www.mitrabiotech.com
Champions Oncology was founded by renowned specialists in the field of cancer diagnosis, treatment, and research. The Champions Oncology team is comprised of seasoned oncology professionals passionately dedicated to working to accelerate oncology drug development, improve treatment outcomes and extend lives. Champions Personalized TumorGrafts™ empower patients and physicians using an in vivo xenograft mouse avatar-based diagnostic model that has shown to be predictive of a patients’ clinical response. championsoncology.com
Hera Biolabs, Inc., is an innovative pre-clinical contract research organization [CRO] utilizing cutting-edge gene-editing technologies to create novel in vivo models for oncology. Given our mission to accelerate cancer research and drug development, we focus upon rat models to deliver translationally-relevant, high-quality results.
Using proprietary technologies, Hera built the SRGTM Platform, a double knockout Sprague-Dawley rat engineered for T-cell, B-cell, and NK cell deficiency. Our first SRG model is the OncoRat®, uniquely suited for xenograft studies given its excellent tumor take-rates and ability to deliver masses 10x that of mouse models in half the time – all without the increased risk of genetic drift from multiple passages as observed in mice.
To facilitate immuno-oncology studies, a humanized SRG Model – the ImmunoRatTM – is in development. We’re continuing to use our proprietary Cas-CLOVERTM CRISPR System and piggyBacTM gene-editing technologies and know-how to expand our robust pipeline of animal models and services.
As a spinout of Transposagen Biopharmaceuticals, Inc., Hera BioLabs is based in Lexington, KY. Our vivarium features a dual HEPA-filtered, disposable IVC rodent caging system, and the facility has successfully passed multiple audits by our happy clients. Pre-clinical research services are provided by Hera’s knowledgeable, friendly, customer-focused team. To learn more, please visit us at https://www.herabiolabs.com
MI Bioresearch (MI), a preclinical oncology service provider, offers in vitro services, oncology pharmacology, in vivo imaging, and focal radiation to support research programs. Our team explores the effects of your drugs and biologics using both human and syngeneic models and multi-modality imaging systems. MI provides you with decision-driving data to help advance your drug candidate toward the next cancer research breakthrough. One Focus. One Purpose. Oncology Research.
Pharmatest Services Ltd is a CRO offering preclinical efficacy services for the pharmaceutical industry. We offer bothin vitro and in vivo models in the fields of oncology and skeletal diseases. In oncology we have special expertise in clinically predictive orthotopic and metastasis models, and especially models of bone metastasis. www.pharmatest.com
Studylog’s Animal Study Workflow Software® is designed for biomedical animal research and provides features for the design, planning, execution, analysis, and reporting of animal studies in a standardized, highly efficient manner, while protecting data integrity.
Reducing many labs’ study-related labor by half, Studylog automates and streamlines the entire animal study process, making it easier, faster and cheaper, so researchers have more time and resources to get their job done.
Repositive is a technology company with the mission to increase discovery, access and sharing of genomic data for the benefit of patients. In 2017 we initiated a collaboration with leading biopharma organisations and CROs to launch the Cancer Models Platform to act as a market place of translational oncology models and a network for oncology researchers… Read More